We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio

News   May 10, 2012

 
QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
 
 
Advertisement
 

RELATED ARTICLES

Mass Spectrometrists Around the World Pull Together To Share COVID-19 Data

News

A new coalition of more than 500 scientists from around the world has been created to share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.

READ MORE

Blood Markers of Fitness Identified

News

A simple blood test may be able to determine how physically fit you are, according to a new study conducted by scientists at the Stanford University School of Medicine.

READ MORE

Markers in Blood Can Help Identify Risk for Complications After Mild TBI

News

Molecules released into the blood following mild traumatic brain injury may be indicators of neuronal damage associated with complications, according to new research.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE